Feiyu Du

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.

  PubMed · 2025-12-09

• Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial

  Blood · 2024-11-05 · 1 citations

• 76. Automating immunogenomic tumor board decision-making for neoantigen cancer vaccine design

  Cancer Genetics · 2024-08-01

• 11. Developing a robust bioinformatics workflow to support personalized neoantigen vaccine clinical trials

  Cancer Genetics · 2024-08-01